Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 1999

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions
Psoriasis Vulgaris
Interventions
DEVICE

Phototherapy

The patient begins total body NBUVB that day at a dose that is 50% of the MED. Patients are treated 3-7 times per week, with increasing doses at every treatment if no burning occurs. This is continued until clearance of disease or maximum efficacy.

Trial Locations (1)

10021

Rockefeller University Hospital, New York

All Listed Sponsors
lead

Mary Sullivan-Whalen

OTHER

NCT00220025 - Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris. | Biotech Hunter | Biotech Hunter